Machine-learning models analyze gut bacteria to predict biological aging pace; Bifidobacterium linked to slower aging, Succinivibrio to acceleration. A 2024 study unveils EpiBiome models that predict ...
A woman’s death after an unapproved NAD+ IV infusion highlights the dangers of unregulated longevity treatments and the gap between hype and evidence. A tragic death linked to unregulated NAD+ i...
Fermented foods like kimchi and kefir are trending, but not all products deliver proven benefits. This analysis reviews the latest science and regulatory gaps. From TikTok trends to grocery aisles, fe...
As AI increasingly aids clinical decisions, the concept of ‘Clinical Cognitive Interaction’ emerges as a critical physician skill to balance benefits and risks. New framework calls for phy...
Recent research links specific gut microbes to epigenetic aging clocks, suggesting targeted probiotics could slow biological aging. Scientists have identified microbial species that either accelerate ...
Despite validated p-tau217 blood tests for early Alzheimer’s prediction, clinical adoption lags due to lack of interventions and standardized protocols. Blood biomarker p-tau217 can predict Alzh...
AI hallucinations in large language models pose serious risks for patient education and clinical decisions. Recent studies show up to 30% inaccuracies, requiring urgent oversight and verification prot...
UCSF’s Converge initiative and similar accelerators are transforming how health systems deploy AI, challenging legacy EHR vendors and speeding up clinical innovation. Inside-out AI accelerators ...
TytoCare’s FDA-cleared AI devices and $25M funding highlight how remote monitoring cuts hospital visits and improves outcomes for CHF and COPD patients. AI-driven remote monitoring is shifting c...
A review lists LLM opportunities and ethical challenges as if symmetrical. They aren’t. Privacy and security are hard but tractable; subgroup reliability, genuine explainability and accountabili...